M
Michael Steinbuch
Researcher at Procter & Gamble
Publications - 33
Citations - 3350
Michael Steinbuch is an academic researcher from Procter & Gamble. The author has contributed to research in topics: Risk factor & Odds ratio. The author has an hindex of 22, co-authored 33 publications receiving 3206 citations. Previous affiliations of Michael Steinbuch include University of Nebraska Medical Center & University of Minnesota.
Papers
More filters
Journal ArticleDOI
Allogeneic sibling umbilical-cord-blood transplantation in children with malignant and non-malignant disease
TL;DR: It is concluded that umbilical cord blood is a sufficient source of transplantable haemopoietic stem cells for children with HLA-identical or Hla-1 antigen disparate sibling donors with very low risk of acute or extensive chronic GVHD.
Journal ArticleDOI
An assessment tool for predicting fracture risk in postmenopausal women.
Dennis M. Black,Michael Steinbuch,Lisa Palermo,Patricia Dargent-Molina,Robert Lindsay,M S Hoseyni,Olof Johnell +6 more
TL;DR: The FRACTURE Index can be used either with or without BMD testing by older postmenopausal women or their clinicians to assess the 5-year risk of hip and other osteoporotic fractures, and could be useful in helping to determine the need for further evaluation and treatment of these women.
Journal ArticleDOI
Malignant neoplasms following bone marrow transplantation.
Smita Bhatia,Norma K.C. Ramsay,Michael Steinbuch,Kathryn E. Dusenbery,R. S. Shapiro,Daniel J. Weisdorf,Leslie L. Robison,Jeffrey S. Miller,Joseph P. Neglia +8 more
TL;DR: Recipients of bone marrow transplant (BMT) are at an increased risk of later malignancy, which may add significant morbidity and mortality to the transplant process.
Journal ArticleDOI
Fragility fractures of the hip and femur: incidence and patient characteristics
Jeri W. Nieves,J. P. Bilezikian,Joseph M. Lane,Thomas A. Einhorn,Yamei Wang,Michael Steinbuch,Felicia Cosman +6 more
TL;DR: Hip fracture incidence is declining but the incidence of each of the more rare femur fractures (distal to the lesser trochanter) is stable over time.
Journal ArticleDOI
Oral glucocorticoid use is associated with an increased risk of fracture
TL;DR: Previous observations that suggest oral GCs have a rapid deleterious effect on trabecular-rich bone are confirmed and the emerging relationship between amount, duration, and pattern of oral GC exposure and fracture risk should be considered in clinical practice and managed care settings.